|
Case
Report
Hobnail
Variant Papillary Thyroid Carcinoma :
A Rare Entity with Aggressive
Behaviour
Authors:
Jayanth
Pothedar, Resident
(Pathology),
Natasha Dogra,
Classified Specialist Path and OncoPath,
Abhishek Singh, Graded
Specialist Path,
Deepti Mutreja, Senior
Advisor, Professor and Head,,
Jeenu Varghese, Graded
Specialist Path,
Gurpreet Kaur, Graded
Specialist Path,
Department of Laboratory
Medicine, Command Hospital Airforce,
Bangalore, Karnataka, India.
Address for
Correspondence
Dr Jayanth
Pothedar,
Resident (Pathology),
Department of Laboratory Medicine,
Command Hospital Airforce,
Bangalore, Karnataka, India.
E-mail:
pothedar.jayanth121@gmail.com.
Citation
Pothedar J, Dogra N,
Singh A, Mutreja D, Varghese J, Kaur G.
Hobnail Variant Papillary Thyroid
Carcinoma : A Rare Entity with
Aggressive Behaviour. Online J
Health Allied Scs. 2025;24(4):5.
Available at URL:
https://www.ojhas.org/issue96/2025-4-5.html
Submitted:
Feb
11, 2025; Accepted: Mar 7, 2025;
Published: Jan 31, 2026
|
|
|
|
|
Introduction
Hobnail
variant of papillary thyroid carcinoma (HV-PTC) is
an unusual entity recently included in WHO
classification of endocrine tumors (2017) and
proposed as an aggressive variant of PTC. Compared
to patients of classical counterparts, HV-PTC
frequently has extrathyroidal extension, exhibits
nodal or distant metastasis, and responds poorly
to radioiodine treatment, leading to increased
mortality.[1] The pathologist is
instrumental in the diagnosis of HV-PTC. It is a
diagnostic challenge which can be resolved by
close attention to morphology, clinicoradiological
correlation along with Immunohistochemical and
molecular studies in some cases.
Case History
A 68 year old male
patient , known case of coronary artery disease,
hypertension, aortic aneurysm presented with
swelling over the neck and change in voice for
last 05 months. CECT neck and chest was done which
revealed a large hypodense enhancing nodule
measuring 2.9x2.7x.3.7 cm (APxTRxCC) is seen
epicentered at superior aspect of right lobe of
thyroid gland. FNAC was performed which was opined
as Bethesda category V suspicious for Papillary
Thyroid Carcinoma (PTC). Considering the strap
muscle involvement radiologically and
intraoperatively, total thyroidectomy was
performed.

|
| Fig
1: A brownish nodule is noted grossly on
superior pole of thyroid lobe measuring
3x2 cm. Capsular breach seen. Gross
capsular invasion present. |

|
| Fig
2: CECT Neck and Chest: In
Axial view, a large hypodense enhancing
nodule measuring 2.9x2.7x3.7 cm (APxTRcCC)
is seen epicentered at superior aspect of
right lobe of thyroid gland. Left lobe and
isthumus appear normal. A large hypodense
enhancing nodule measuring 2.9x2.7x3.7 cm
(APxTRcCC) is seen epicentered at superior
aspect of right lobe of thyroid gland.
Left lobe and isthmus appear normal. |
Intraoperatively and
on gross findings, there was hard nodule of size 3
x 2 cm involving right superior lobe. Strap muscle
involvement was seen. Another nodule was noted
measuring 0.7x 0.7x 0.7 cm on superior pole of
right thyroid. Left lobe of thyroid and isthmus
were normal.

|
| Fig
3: Histopathological sections
from right lobe of thyroid show presence
of tumour arranged in arborising papillary
architecture with fibrovascular cores.
Numerous micro papillae seen with
hyalinised cores at places >30% of
lining cells have nuclei at the surface
and show hob nailing. |
Microscopically
sections from right lobe of thyroid showed
presence of tumour arranged in arborising
papillary architecture with fibrovascular cores.
The cores at places appeared hyalinised. More than
30% of lining cells showed loss of polarity,
relatively high N: C ratio with apical nuclei at
the surface and showing a surface bulge/ hob nail
appearance. Focal areas less than 10 % showed tall
cell changes. The tumour is seen to be breaching
the thyroid capsule and invading the adjoining
strap muscle. Optically clear nuclei with
marginated chromatin, nuclear grooving and
occasional intranuclear inclusions were seen. Foci
of squamoid differentiation were noted.
Microscopic strap muscle involvement was noted .
Left thyroid showed normal histomorphology and was
free from tumor.

|
| Fig
4: Immunohistochemistry shows
(A) Strong nuclear positivity for PAX8
(IHC, 400x); (B) nuclear positivity for
TTF-1 (IHC, 400x) |
The final opinion
rendered was Hobnail variant of papillary thyroid
carcinoma (HV-PTC). Stage : pT3b Nx Mx (AJCC 8th
edition)
Discussion
HV-PTC is a rare
variant of PTC that comprise of 0.2% to 0.3% of
PTC. The diagnosis of this variant has been
recently defined by the presence of at least 30%
of cells with hobnail features. It has been
advocated that with this higher percentage of
hobnail/ micropapillary features, the tumours are
associated with very aggressive behaviour and
significant mortality[2,3]. Tumour with even 10%
hobnail features also carry a poor outcome. Eighty
percent of tumors undergoing mutational analysis
had the BRAFV600E mutation,
and the remaining 20% harbored a RET/PTC1
gene rearrangement. Though HVPTC displays a
spectrum of papillary arrangement with
predominance of micropapillary structures with
hobnail cells, conspicuous nucleoli and
intranuclear, cytoplasmic inclusions but the
typical nuclear features of papillary thyroid
carcinoma is seldom present. HVPTC is associated
with aggressive features (old age, lymphovascular
invasion, lymph node metastasis, distant
metastasis, high stage) along with genetic
features of BRAF mutation in 72%, p53 mutation in
56% and h-TERT mutation in 44% but strikingly
RET/PTC rearrangement is absent unlike classic
variant of PTC. There is lymph node metastasis of
60–75% cases and that of distant spread in 25–40%
cases.[1]
The differential
diagnosis includes diffuse sclerosing variant of
PTC (DS-PTC). However DS-PTC is associated with
squamous metaplasia, fibrosis, and abundant
psammoma bodies. Medullary thyroid carcinoma with
discohesive cells may overlap with cytologic
features with HV-PTC. IHC with calcitonin renders
a correct diagnosis.
In a recent study
HV-PTC showed high rates of extra-thyroidal
extension (40.4%), lymph node metastasis (68.1% of
patients with lymphadenectomy), and vascular
emboli (49.5%), with no differences according to
the 30% cutoff. On the other hand, distant
metastases were present in HVPTC only (9.4%).
Also, advanced age, advanced disease stage, and TERT
promoter mutation were associated with HVPTC. More
than half of the patients with follow-up had
structural or biochemical persistence after 1 year
from surgery[4]. Tumors, such as serous
and clear cell carcinoma of ovary, micropapillary
breast carcinoma, carcinoma colon, and lung
micropapillary adenocarcinoma, which are common
mimickers of HV-PTC are differentiated on basis of
clinicoradiological input and immunohistochemical
markers of WT1, PAX8, GATA3, CDX2, and Napsin-A.
Our study showed positivity for TTF1, PAX8 and
Beta catenin and negativity for CDX2. This
supports the diagnosis of HV-PTC.
Conclusion
Papillary carcinoma
thyroid, Hobnail variant (HV-PTC) is a recently
described rare variant of PTC . Due to its
association with aggressive behaviour and
metastasis, appropriate diagnosis, surgical
intervention and treatment will improve overall
survival of the patient. PTC with even focal
hobnail component is characterized by the high
frequency of regional metastases at the moment of
primary tumor manifestation. The clinicians,
pathologists and patients should be aware about
this unusual variant and its behaviour so as to
enable correct diagnosis, prognostication and
treatment.
References
- Mohapatra D, Naik S, Das P, Agrawala S.
Metastatic hobnail variant of papillary thyroid
carcinoma: A diagnostic challenge in cell block
preparation. Indian J Pathol Microbiol. 2021
Apr-Jun;64(2):358-361. doi:
10.4103/IJPM.IJPM_381_20.
- Lee YS, Kim Y, Jeon S, Bae JS, Jung SL, Jung
CK. Cytologic, clinicopathologic, and molecular
features of papillary thyroid carcinoma with
prominent hobnail features: 10 case reports and
systematic literature review. Int J Clin Exp
Pathol. 2015 Jul 1;8(7):7988-97.
- Asioli S, Erickson LA, Sebo TJ, Zhang J, Jin
L, Thompson GB, et al. Papillary
thyroid carcinoma with prominent hobnail
features: A new aggressive variant of moderately
differentiated papillary carcinoma. A
clinicopathologic, immunohistochemical, and
molecular study of eight cases. Am J Surg
Pathol 2010;34:44-52
- Poma AM, Macerola E, Proietti A, Vignali P,
Sparavelli R, Torregrossa L, Matrone A, Basolo
A, Elisei R, Santini F, Ugolini C.
Clinical-Pathological Features and Treatment
Outcome of Patients With Hobnail Variant
Papillary Thyroid Carcinoma. Front
Endocrinol (Lausanne). 2022 Mar
2;13:842424. doi: 10.3389/fendo.2022.842424.
|